Figure 2.
Figure 2. Overall survival of relapsed/refractory MM patients treated with thalidomide according to XRCC5 (rs1051685) genotype (AA=wild type, AG=heterozygous SNP).

Overall survival of relapsed/refractory MM patients treated with thalidomide according to XRCC5 (rs1051685) genotype (AA=wild type, AG=heterozygous SNP).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal